Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data-Reference-Cited by-同舟云学术

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data

Published:2020-12 Issue: Volume:Volume 13 Page:4697-4711
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Giacobbe Daniele Roberto^ORCID,Ciacco Eugenio,Girmenia Corrado^ORCID,Pea Federico,Rossolini Gian Maria,Sotgiu Giovanni^ORCID,Tascini Carlo,Tumbarello Mario,Viale Pierluigi,Bassetti Matteo

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference78 articles.

1. Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers

2. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

3. Global antimicrobial resistance in Gram-negative pathogens and clinical need

4. Management of KPC-producing Klebsiella pneumoniae infections

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria;Current Opinion in Infectious Diseases;2024-08-01

2. Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study;Infectious Diseases and Therapy;2024-07-12

3. Clonal expansion and rapid characterization of Klebsiella pneumoniae ST1788, an otherwise uncommon strain spreading in Wales, UK;Microbial Genomics;2023-09-05

4. In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors;JAC-Antimicrobial Resistance;2023-09-04

5. Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Acinetobacter baumannii;Antibiotics;2023-07-20